Published in Chest on November 01, 1981
Induced sputum and bronchoscopy in the diagnosis of pulmonary tuberculosis. Thorax (2002) 1.30
Role of fibreoptic bronchoscopy in the diagnosis of mycobacterial diseases. Thorax (1983) 0.89
Atypical presentations of pulmonary tuberculosis diagnosed by fibreoptic bronchoscopy. Postgrad Med J (1993) 0.87
The value of routinely culturing for tuberculosis during bronchoscopies in an intermediate tuberculosis-burden country. Yonsei Med J (2007) 0.82
A study on rapid confirmation of pulmonary tuberculosis in smear-negative acid fast bacilli cases by using fiberoptic bronchoscopy, done through a trans oro pharyngeal spacer. J Family Community Med (2012) 0.80
Current status of fibreoptic bronchoscopy. Postgrad Med J (1984) 0.75
Primary mediastinal tumors: part II. Tumors of the middle and posterior mediastinum. Chest (1997) 4.10
Superior pulmonary sulcus tumors and Pancoast's syndrome. N Engl J Med (1997) 3.29
Primary mediastinal tumors. Part 1: tumors of the anterior mediastinum. Chest (1997) 2.91
Etiologic considerations in superior vena cava syndrome. Mayo Clin Proc (1981) 2.71
Pulmonary arteriovenous fistulas. Mayo Clin Proc (1974) 2.64
Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial. Ann Intern Med (1991) 2.37
Giant left atrium as a cause of dysphagia. Ann Intern Med (1966) 2.10
The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc (1980) 2.01
Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography. Chest (1990) 1.99
Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest (1992) 1.80
Pulmonary arteriovenous fistulas. Mayo Clin Proc (1983) 1.79
Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review. Mayo Clin Proc (1987) 1.78
A new immunodeficiency disorder in humans involving NK cells. Nature (1980) 1.78
Chronic nitrofurantoin pulmonary reaction. Report of 5 cases. N Engl J Med (1968) 1.67
Malignant pulmonary neoplasms predisposing to spontaneous pneumothorax. Mayo Clin Proc (1973) 1.66
Hepatopulmonary syndrome. Clinical observations and lack of therapeutic response to somatostatin analogue. Chest (1993) 1.61
Pleural effusion. A diagnostic dilemma. JAMA (1976) 1.56
Approach to the solitary pulmonary nodule. Mayo Clin Proc (1993) 1.51
Hepatopulmonary syndrome. Current concepts in diagnostic and therapeutic considerations. Chest (1994) 1.50
An integrated approach to evaluation of the solitary pulmonary nodule. Mayo Clin Proc (1990) 1.47
Chédiak-Higashi gene in humans. II. The selectivity of the defect in natural-killer and antibody-dependent cell-mediated cytotoxicity function. J Exp Med (1980) 1.41
Referral selection bias in the Medicare hospital mortality prediction model: are centers of referral for Medicare beneficiaries necessarily centers of excellence? Health Serv Res (1994) 1.37
Bolus versus infusion regimens of etoposide and cisplatin in treatment of non-small cell lung cancer: a study of the North Central Cancer Treatment group. J Natl Cancer Inst (1990) 1.37
Solitary plasmacytoma of the trachea. Am Rev Respir Dis (1965) 1.34
The correlation of emphysema or airway obstruction with the risk of lung cancer: a matched case-controlled study. Eur Respir J (2002) 1.33
Neodymium-YAG laser therapy of malignant airway obstruction. A preliminary report. Mayo Clin Proc (1983) 1.32
Transthoracic needle biopsy: accuracy and complications in relation to location and type of lesion. Mayo Clin Proc (1980) 1.32
Detecting intrapulmonary right-to-left shunt with contrast echocardiography. Observations in a patient with diffuse pulmonary arteriovenous fistulas. Mayo Clin Proc (1976) 1.31
Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer. Clin Cancer Res (1996) 1.29
Roentgenographically occult lung cancer: pathologic findings and frequency of multicentricity during a 10-year period. Mayo Clin Proc (1984) 1.27
Bronchopulmonary helminthosporiosis. Am J Clin Pathol (1970) 1.26
Typical and atypical pulmonary carcinoids : outcome in patients presenting with regional lymph node involvement. Chest (2001) 1.21
Usefulness of chromosome examination in the diagnosis of malignant pleural effusions. N Engl J Med (1976) 1.20
A two-year experience with the neodymium-YAG laser in endobronchial obstruction. Chest (1987) 1.19
Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer. J Clin Oncol (1994) 1.18
Hepatopulmonary syndrome: an evolving perspective in the era of liver transplantation. Hepatology (1990) 1.17
Augmentation of human monocyte-mediated cytolysis by interferon. Cell Immunol (1980) 1.17
Endoscopic management of lung cancer with hematoporphyrin derivative phototherapy. Mayo Clin Proc (1982) 1.15
A phase II trial of imatinib (ST1571) in patients with c-kit expressing relapsed small-cell lung cancer: a CALGB and NCCTG study. Ann Oncol (2005) 1.15
Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients. Mayo Clin Proc (1996) 1.13
Interstitial lung disease. Assessment by bronchoalveolar lavage. Mayo Clin Proc (1983) 1.12
Pulmonary arteriovenous fistulas. Ann Thorac Surg (1969) 1.11
Erdheim-Chester disease: clinical, radiologic, and histopathologic findings in five patients with interstitial lung disease. Am J Surg Pathol (1999) 1.10
Thermal considerations in murine tumor killing using hematoporphyrin derivative phototherapy. Cancer Res (1983) 1.08
Dumbbell neurogenic tumors of the mediastinum. Diagnosis and management. Mayo Clin Proc (1978) 1.06
Roentgenographically occult lung cancer. A ten-year experience. J Thorac Cardiovasc Surg (1983) 1.05
Severe hypoxemia associated with liver disease: Mayo Clinic experience and the experimental use of almitrine bismesylate. Mayo Clin Proc (1987) 1.05
Mediastinal granuloma and fibrosing mediastinitis. Chest (1979) 1.05
Fat embolism and the adult respiratory distress syndrome. Mayo Clin Proc (1974) 1.04
The flow-volume loop and main-stem bronchial obstruction. Am Rev Respir Dis (1988) 1.02
Photoradiation therapy in the treatment of malignant brain tumors: a phase I (feasibility) study. Neurosurgery (1981) 1.02
Esophageal involvement with mediastinal granuloma. JAMA (1976) 0.99
Diagnostic significance of pneumatocele of the lung. JAMA (1968) 0.99
Biopsy and brushing of peripheral lung cancer with fluoroscopic guidance. Chest (1979) 0.99
Failure of hepatopulmonary syndrome to resolve after liver transplantation and successful treatment with embolotherapy. Hepatology (1995) 0.99
Acquired immunodeficiency syndrome associated with blood-product transfusions. Ann Intern Med (1983) 0.99
Severe hypoxemia and liver disease. Am Rev Respir Dis (1989) 0.98
Solitary pulmonary nodule: CT evaluation of enhancement with iodinated contrast material--a preliminary report. Radiology (1992) 0.98
Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial. J Clin Oncol (1994) 0.98
Aspiration pneumonitis. Mayo Clin Proc (1970) 0.98
Diffuse malignant mesothelioma of pleura. Diagnosis and survival in 92 cases. Cancer (1986) 0.97
Bronchoscopic phototherapy with hematoporphyrin derivative for treatment of localized bronchogenic carcinoma: a 5-year experience. Mayo Clin Proc (1987) 0.97
Paclitaxel and G-CSF in previously untreated patients with extensive stage small-cell lung cancer: a phase II study of the North Central Cancer Treatment Group. Am J Clin Oncol (1999) 0.96
Management of malignant airway compromise with laser and low dose rate brachytherapy. The Mayo Clinic experience. Chest (1988) 0.95
Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma. J Clin Oncol (1999) 0.95
Airway obstruction due to inhalation of ammonia. Mayo Clin Proc (1983) 0.94
Leukoencephalopathy in small cell lung cancer patients receiving prophylactic cranial irradiation. Am J Clin Oncol (1989) 0.94
Hematoporphyrin derivative: quantitative uptake in dimethylhydrazine-induced murine colorectal carcinoma. J Surg Oncol (1983) 0.93
Disseminated Strongyloides stercoralis in an immunosuppressed host. Mayo Clin Proc (1978) 0.92
Aspiration pneumonia. Chest (1974) 0.92
Treatment of transitional cell carcinoma of the bladder with hematoporphyrin derivative phototherapy. J Urol (1983) 0.92
Primary mediastinal choriocarcinoma. Mayo Clin Proc (1968) 0.91
Prophylactic cranial irradiation in complete responders with small-cell lung cancer: analysis of the Mayo Clinic and North Central Cancer Treatment Group data bases. J Clin Oncol (1994) 0.91
Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study. J Clin Oncol (1996) 0.91
Acute bronchiolitis as a cause of chronic obstructive lung disease in adults. Report of two cases. J Lancet (1967) 0.90
Detection and localization of In situ carcinoma of the bladder with hematoporphyrin derivative. Mayo Clin Proc (1982) 0.90
Endothelium-derived relaxing factor in pulmonary and renal circulations during hypoxia. Am J Physiol (1992) 0.89
Sarcoidosis associated with regional enteritis (Crohn's disease). Minn Med (1971) 0.89
Lung cancer: current concepts and prospects. CA Cancer J Clin (1983) 0.89
Recurrent spontaneous pneumothorax in diffuse scleroderma. Report of a case. Dis Chest (1966) 0.89
Pulmonary aspects of liver disease and liver transplantation. Clin Chest Med (1989) 0.89
Mediastinal granuloma. Mayo Clin Proc (1975) 0.89
The significance of a cytologically negative pleural effusion in bronchogenic carcinoma. Chest (1978) 0.88
Respiratory tract Aspergillus: clinical significance. Minn Med (1980) 0.88
Pulmonary actinomycosis. Report of 18 cases. Minn Med (1971) 0.88
Pulmonary lymphangiomyomatosis: with particular reference to steroid-receptor assay studies and pathologic correlation. Mayo Clin Proc (1984) 0.88
Pulmonary resection of metastatic colorectal adenocarcinoma. A ten year experience. Chest (1986) 0.87
The fat-embolism syndrome. Surg Clin North Am (1969) 0.87
Hematoporphyrin derivative in the detection and localization of radiographically occult lung cancer. Am Rev Respir Dis (1982) 0.87
The value of cells in the pleural fluid in the differential diagnosis. Mayo Clin Proc (1975) 0.87
A prospective study of pulmonary function and gas exchange following liver transplantation. Chest (1992) 0.87
Pulmonary resection of metastatic renal cell carcinoma. Chest (1983) 0.87
Nontuberculous pulmonary parenchymal conditions predisposing to spontaneous pneumothorax. Report of four cases. J Thorac Cardiovasc Surg (1967) 0.86
Preoperative evaluation of the patient with pulmonary disease. Mayo Clin Proc (1973) 0.86
Clinical application of a new endoscopic technique for detection of in situ bronchial carcinoma. Mayo Clin Proc (1979) 0.85
A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinoma. Cancer (1992) 0.85
p21waf1/cip1 and transforming growth factor beta 1 protein expression correlate with survival in non-small cell lung cancer. Clin Cancer Res (1998) 0.84